Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $59.54 million. The enterprise value is $27.85 million.
Important Dates
The last earnings date was Tuesday, April 15, 2025, before market open.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADVM has 20.89 million shares outstanding. The number of shares has increased by 96.21% in one year.
| Current Share Class | 20.89M |
| Shares Outstanding | 20.89M |
| Shares Change (YoY) | +96.21% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 11.79% |
| Owned by Institutions (%) | 52.30% |
| Float | 12.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.55 |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.73, with a Debt / Equity ratio of 1.30.
| Current Ratio | 5.73 |
| Quick Ratio | 5.49 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -189.84% and return on invested capital (ROIC) is -57.28%.
| Return on Equity (ROE) | -189.84% |
| Return on Assets (ROA) | -51.83% |
| Return on Invested Capital (ROIC) | -57.28% |
| Return on Capital Employed (ROCE) | -88.67% |
| Revenue Per Employee | $6,452 |
| Profits Per Employee | -$844,690 |
| Employee Count | 155 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.43% in the last 52 weeks. The beta is 1.09, so ADVM's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -74.43% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 5.96 |
| Relative Strength Index (RSI) | 34.35 |
| Average Volume (20 Days) | 208,431 |
Short Selling Information
The latest short interest is 1.49 million, so 7.11% of the outstanding shares have been sold short.
| Short Interest | 1.49M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 7.11% |
| Short % of Float | 11.78% |
| Short Ratio (days to cover) | 9.77 |
Income Statement
In the last 12 months, ADVM had revenue of $1.00 million and -$130.93 million in losses. Loss per share was -$6.62.
| Revenue | 1.00M |
| Gross Profit | -76.04M |
| Operating Income | -139.16M |
| Pretax Income | -113.99M |
| Net Income | -130.93M |
| EBITDA | -135.51M |
| EBIT | -139.16M |
| Loss Per Share | -$6.62 |
Full Income StatementBalance Sheet
The company has $125.69 million in cash and $91.71 million in debt, giving a net cash position of $33.99 million or $1.63 per share.
| Cash & Cash Equivalents | 125.69M |
| Total Debt | 91.71M |
| Net Cash | 33.99M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 70.71M |
| Book Value Per Share | 3.39 |
| Working Capital | 108.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$92.46 million and capital expenditures -$388,000, giving a free cash flow of -$92.85 million.
| Operating Cash Flow | -92.46M |
| Capital Expenditures | -388,000 |
| Free Cash Flow | -92.85M |
| FCF Per Share | -$4.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -13,915.90% |
| Pretax Margin | -13,092.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -96.21% |
| Shareholder Yield | -96.21% |
| Earnings Yield | -211.73% |
| FCF Yield | -150.16% |
Analyst Forecast
The average price target for ADVM is $25.83, which is 806.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.83 |
| Price Target Difference | 806.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 136.67% |
| EPS Growth Forecast (5Y) | -13.46% |
Stock ForecastsStock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Mar 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
ADVM has an Altman Z-Score of -9.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.12 |
| Piotroski F-Score | 2 |